..............page:899-901
..............page:902-904
..............page:905-908
..............page:909-911,915
..............page:912-915
..............page:916-920
..............page:921-923
..............page:924-927
..............page:928-931
..............page:932-934,959
..............page:935-937
..............page:938-941
..............page:942-945
..............page:946-949
..............page:950-953
..............page:957-959
..............page:960-963
..............page:970-975
..............page:976-983
..............page:984-989
..............page:990-992,1000
..............page:993-1000
..............page:1001-1006
..............page:1007-1013,1021
..............page:1014-1021
..............page:1022-1026
..............page:1027-1030
..............page:1031-1037
..............page:1038-1041
..............page:1042-1043,1062
..............page:1044-1048
..............page:1049-1052
..............page:1053-1055
..............page:1056-1059
..............page:1060-1062
..............page:1066-1068
Chinese experts′consensus on protocol of breakpoints setting of new antibacterial agents for clinical trial
LI Yun;,ZHENG Bo;,LV Yuan;,WEI Min-ji;,SHAN Ai-lian;,CAO Zhao-long;,LI Ruo-yu;,LIAO Qin-ping;,LIN Ming-gui;,LV Xiao-ju;,MA Xiao-jun;,NI Yun-xing;,TONG Ming-qing;,WANG Rui;,XU Ying-chun;,YOU Xue-fu;,ZHANG Jing;,ZHANG Qiong;,ZHANG Sui-yang;,ZHAO Ming;,ZHENG Qing-shan;,ZHUO Chao;
..............page:1069-1076